Robert Scott

Dr. Robert A. Scott, MD, is an Independent Director at Arcutis Biotherapeutics, Inc., a Chief Medical Officer, Head-Research & Development at ABIONYX Pharma SA and an Independent Director at Confo Therapeutics NV.
He is on the Board of Directors at Arcutis Biotherapeutics, Inc., Redx Pharma Ltd., Confo Therapeutics NV, Variant Bio, Inc., Draupnir Bio ApS and OncoSpherix, Inc. Dr. Scott was previously employed as a Lead Independent Director by Windtree Therapeutics, Inc., a Chief Medical Officer & Head-Development by AbbVie SA, a VP & Head-Global Cardiovascular Development by Amgen, Inc., a Chief Medical Officer by Cerenis Therapeutics, Inc., and a Principal by Pfizer Inc. He also served on the board at ArisGlobal LLC, AtheroGenics, Inc. and Transcelerate Biopharma, Inc. He received his undergraduate degree from the University of Cape Town and a doctorate degree from the University of Cape Town.